| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/04/2006 | US7071207 Suppression appetite; induction weight loss |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070800 Inhalable powder containing tiotropium |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006068618A1 New compounds |
| 06/29/2006 | WO2006068162A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 06/29/2006 | WO2006068058A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | WO2006067807A1 Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
| 06/29/2006 | WO2006067600A2 Herbal formulations as cough lozenge |
| 06/29/2006 | WO2006067444A1 Amide derivatives |
| 06/29/2006 | WO2006066929A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | WO2006066928A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 06/29/2006 | WO2006066924A2 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | WO2006066907A1 Pharmaceutical formulations |
| 06/29/2006 | WO2006066780A1 Combinations of valategrast and montelukast for treating asthma |
| 06/29/2006 | WO2006066509A1 Injectable sustained release microspheric preparation of 3,3-diphenylpropylamine derivatives as muscarinic receptor antagonists |
| 06/29/2006 | WO2006066500A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | WO2006042950A3 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 06/29/2006 | WO2006030322A3 Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142308 Synergistic combination comprising roflumilast and formoterol |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060140981 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | CA2591940A1 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2591083A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/29/2006 | CA2589133A1 Quaternary ammonium salts as m3 antagonists |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674084A2 Extended release oral dosage composition |
| 06/28/2006 | EP1673345A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 06/28/2006 | EP1673086A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 06/28/2006 | EP1673080A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | CN1795176A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1795169A Crystalline form of beta2 adrenergic receptor agonist |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1794988A Method for treating vascular hyperpermeable disease |
| 06/28/2006 | CN1794985A Azabicyclo derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1794984A Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 06/28/2006 | CN1792362A Abiduoer and its salts prepns. for vena administration, and its preparing method |
| 06/28/2006 | CN1792286A Cigarette-like smoking substitute for women use |
| 06/28/2006 | CN1792268A Making method of health-care beverage for efficient preventing and treating asthma |
| 06/28/2006 | CN1792177A Throat-moistening and health-care biscuit |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261125C Chinese herbal medicine for treating acute rhinitis and chronic rhinitis as well as its preparing method |
| 06/28/2006 | CN1261113C Medicine for treating nasosinusitis and preparing method |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261053C Coke drink of Chinese traditional medicine for preventing and treating virulence cold constipation and pneumonia |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067536 phosphodiesterase 4 inhibitors in immunocompetent cells, such as macrophages and lymphocytes; side effect reduction; N-(3,5-dichloro-1-oxopyridin-4-yl)-[7-hydroxy-1-(3- or 2-nitrobenzyl)-indol-3-yl]glyoxylamide |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067502 A medicament containing formoterol or its pharmaceutically acceptable salt and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease |
| 06/27/2006 | US7067493 Single dose azithromycin |
| 06/27/2006 | US7067491 3,3,3-trifluoro-1-(methylethyl)-2-oxopropyl]carbamoyl}pyrrolidinyl) derivatives; useful for prophylaxis and treatment for various diseases caused by increased elastase activity, such as diseases caused by increased protein degradation by elastase, especially respiratory diseases |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |